Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023: -0.41%

Guangdong VTR Bio-Tech Co., Ltd. Return on Equity (ROE) is -0.41% for the year ending December 31, 2023, a -161.02% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Guangdong VTR Bio-Tech Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 0.67%, a 115.82% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was -4.26%, a -178.41% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 5.43%, a 4.97% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was 5.17%, a -2.38% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email